|
You have been chosen to receive this valuable information.
|
|
|
|
|
|
Poster on Improving Titers and Shortening Timelines by Combining Beacon® Platform and GPEx® Cell Line Development
|
|
|
Shortening timelines to generate more productive, stable and high expressing cell lines is the goal of any cell line development program. View the technical poster to learn how combining Catalent’s GPEx® cell line development technology with Berkeley Lights, Inc.’s Beacon® platform for clonal cell line selection resulted in stable, higher-expressing clones in a shortened time frame.
Download this poster to learn the following:
Advantages of the GPEx® system, including cell line stability, higher gene expression and no requirement for markers. Advantages of the Beacon® system, including high-throughput automated workflows, shortened timelines, and scalability to identify rare clones. Shortening timelines for cell line selection and generating clones with higher titer.
|
|
|
|
|
Q&A on Removing Formulation Development
from the Critical Path
|
|
|
As product development progresses to phase 3 clinical stage, formulation development is required to ensure drug product quality and stability during manufacturing, storage, and clinical administration. This Q&A discusses how Catalent utilizes automation, specifically the UNcle® platform, during formulation development.
Download this poster to learn the following:
What the UNcle® platform is & its capabilities. Why Catalent adopted the platform. How the platform fits into Catalent's formulation development strategy.
|
|
|
|
|
Poster on Intensified Fed-Batch Process
Utilizing N-1 Perfusion and ambr®15
|
|
|
There is a desire in the industry to intensify the fed-batch process strategy to increase efficiency and productivity. Utilization of perfusion during the N-1 stage allows for inoculation of the production bioreactor at a very high cell density. Learn how to combine N-1 perfusion with the ambr®15 bioreactor system to create a powerful tool for rapid development of a highly efficient cell culture process.
Download this poster to learn the following:
How N-1 perfusion can increase product titer and/or decrease production time. How ambr®15 can be utilized to rapidly screen a variety of media conditions using a DOE approach. How N-1 perfusion and ambr®15 can be utilized together to quickly identify top conditions to scale up to 2L bioreactor.
|
|
|
|
|
|
|
|
|
|
Every molecule has a challenge. We have a solution.
or call +1 877 891 9609 to speak with one of our experts today!
|
|
|
|
|
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at sales@catalent.com, or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.
Catalent Pharma Solutions respects your privacy.
Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement or the website, its owner(s) or the content.
© 2020, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved.
|
|
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
